CINECA IRIS Institutional Research Information System

ANTONIOLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.914
AS - Asia 6.039
EU - Europa 5.888
SA - Sud America 1.029
AF - Africa 344
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.243
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.540
IT - Italia 2.429
CN - Cina 1.774
SG - Singapore 1.772
HK - Hong Kong 1.173
BR - Brasile 881
SE - Svezia 823
DE - Germania 533
BG - Bulgaria 449
VN - Vietnam 392
GB - Regno Unito 344
RU - Federazione Russa 263
CA - Canada 262
TR - Turchia 254
AT - Austria 252
FI - Finlandia 226
IN - India 152
CI - Costa d'Avorio 148
UA - Ucraina 116
KR - Corea 104
FR - Francia 103
NL - Olanda 85
JP - Giappone 80
MX - Messico 63
PL - Polonia 63
AR - Argentina 62
BE - Belgio 45
SN - Senegal 45
BD - Bangladesh 44
PK - Pakistan 42
CH - Svizzera 39
IQ - Iraq 35
NG - Nigeria 33
UZ - Uzbekistan 31
ZA - Sudafrica 30
ID - Indonesia 29
IR - Iran 26
ES - Italia 25
VE - Venezuela 23
MA - Marocco 20
AU - Australia 18
EC - Ecuador 18
EG - Egitto 18
CZ - Repubblica Ceca 16
SA - Arabia Saudita 16
LT - Lituania 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
PY - Paraguay 13
AZ - Azerbaigian 11
KE - Kenya 11
PH - Filippine 11
PT - Portogallo 11
TW - Taiwan 11
IE - Irlanda 10
MY - Malesia 10
CL - Cile 9
DZ - Algeria 9
JM - Giamaica 9
PA - Panama 8
BJ - Benin 7
HN - Honduras 7
IL - Israele 7
TN - Tunisia 7
AL - Albania 6
HU - Ungheria 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LB - Libano 6
NO - Norvegia 6
OM - Oman 6
DO - Repubblica Dominicana 5
NZ - Nuova Zelanda 5
PE - Perù 5
BY - Bielorussia 4
DK - Danimarca 4
GH - Ghana 4
JO - Giordania 4
QA - Qatar 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AO - Angola 3
CG - Congo 3
EU - Europa 3
GD - Grenada 3
NP - Nepal 3
PS - Palestinian Territory 3
UY - Uruguay 3
BS - Bahamas 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
LV - Lettonia 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
SV - El Salvador 2
TH - Thailandia 2
Totale 27.219
Salva come PNG Salva come JPEG
Città #
Ashburn 1.497
Fairfield 1.262
Woodbridge 1.175
Hong Kong 1.144
Singapore 996
Dallas 994
Ann Arbor 940
Houston 847
Chandler 782
Santa Clara 773
Seattle 497
Wilmington 480
Cambridge 448
Sofia 446
Shanghai 438
Milan 402
Beijing 384
Serra 376
New York 328
Boardman 264
Los Angeles 232
Princeton 192
Ottawa 189
Vienna 174
Lawrence 168
Pisa 168
Medford 150
Abidjan 148
Florence 142
Izmir 131
Munich 120
Jacksonville 119
Hefei 118
Dong Ket 116
Des Moines 109
London 102
Rome 95
Nanjing 93
Istanbul 89
Chicago 85
Seoul 84
Bremen 81
Buffalo 79
Redondo Beach 74
São Paulo 74
Dearborn 73
Frankfurt am Main 70
Ho Chi Minh City 61
Turku 57
Tokyo 56
Lucca 55
Lappeenranta 50
Nanchang 49
Council Bluffs 47
Dakar 45
Lancaster 44
Ogden 44
Hanoi 43
Brussels 42
Redwood City 40
San Diego 40
Warsaw 40
Falls Church 39
Columbus 36
Lagos 32
The Dalles 31
Washington 31
Boulder 29
Bern 28
Tashkent 28
Montignoso 27
Nuremberg 27
Pune 27
Phoenix 26
Bologna 25
Guangzhou 25
Rio de Janeiro 25
Toronto 25
Helsinki 24
Livorno 24
Tianjin 24
Changsha 23
Naples 23
Fuzhou 22
Hebei 22
Kunming 22
Montreal 22
Marseille 21
Atlanta 20
Chennai 20
Jüchen 19
Norwalk 19
Brooklyn 18
Porto Alegre 18
Belo Horizonte 17
Jiaxing 16
Kent 16
Shenzhen 16
Brasília 15
Curitiba 15
Totale 19.358
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 501
Preparation of isoindoline derivatives for use as AMPK activators 314
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 283
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 254
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 246
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 243
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 237
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 230
Derivati benzofuranici come attivatori di AMPK 225
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 213
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 203
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 201
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 200
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 196
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 195
CD39 and CD73 in immunity and inflammation 192
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 191
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 190
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 189
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 186
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 186
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 184
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 183
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 182
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 180
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 180
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 179
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 179
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 179
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 178
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 176
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 176
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 176
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 175
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 175
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 175
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 175
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 172
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 172
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 170
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 169
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 169
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 168
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 168
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 165
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 165
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 165
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 164
Allopurinol adherence among patients with gout: an Italian general practice database study 164
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 164
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 163
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 162
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 161
Role of A2a adenosine in the regulation of colonic motility in normal human colon 161
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 161
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 160
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 160
Preparation of benzofuran derivatives for use as AMPK activators 159
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 159
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 157
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 156
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 156
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 156
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 155
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 155
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 155
Donepezil improves vascular function in a mouse model of Alzheimer's disease 155
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 154
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 153
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 153
Transient acute liver failure complicating transurethral resection syndrome 152
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 151
Adenosine and inflammation: what's new on the horizon? 151
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 151
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 149
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 149
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 149
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 149
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 149
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 148
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 148
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 147
Anti-CD73 in cancer immunotherapy: awakening new opportunities 146
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 145
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 145
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 144
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 144
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 144
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 142
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 142
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 142
Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing 142
Risankizumab for the treatment of moderate to severe psoriasis 142
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 141
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 141
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 141
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 141
Adenosine regulation of the immune system 138
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 137
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 137
Totale 17.400
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.122 0 0 0 0 0 81 66 127 229 201 106 312
2021/20222.056 37 87 66 105 390 307 74 115 127 86 138 524
2022/20232.925 334 398 220 282 285 387 37 229 479 49 190 35
2023/20242.469 221 223 285 193 360 427 63 115 106 96 132 248
2024/20256.733 82 252 109 397 552 730 649 299 735 864 710 1.354
2025/20264.330 532 896 1.093 724 855 230 0 0 0 0 0 0
Totale 28.018